Arkolith/Insider Trading/UBX/Form 4

Nguyen Alexander Hieu

CLO and Head of OpsUnity Biotechnology, Inc. (UBX) · full profile →Form 4 · filed Mar 31, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 28, 2025Grant(A)44K—$067K
Mar 27, 2025Sell(S)2K$1.16$2K23K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 28, 2025Grant(A)73K—$073K

Transaction Codes

A
Grant / award
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-047761) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML